GENTAUR Molecular Products.
Monoclonal Antibody, ELISA Kit, Polyclonal Antibody, Recombinant/Purified Protein.Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery
Multidrug and toxin extrusion protein 1 (MATE-1) (hMATE-1) (Solute carrier family 47 member 1)
S47A1_HUMAN Reviewed; 570 AA.
Q96FL8; Q53HF5; Q6PD77; Q86VL4; Q9NVA3;
04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
01-DEC-2001, sequence version 1.
28-FEB-2018, entry version 127.
RecName: Full=Multidrug and toxin extrusion protein 1;
Short=MATE-1;
Short=hMATE-1;
AltName: Full=Solute carrier family 47 member 1;
Name=SLC47A1; Synonyms=MATE1;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
PubMed=14702039; DOI=10.1038/ng1285;
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human
cDNAs.";
Nat. Genet. 36:40-45(2004).
[2]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
TISSUE=Cerebellum;
Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
Tanaka A., Yokoyama S.;
Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
Venter J.C.;
Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
TISSUE=Colon, and Eye;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[5]
FUNCTION, MUTAGENESIS OF GLU-273, TISSUE SPECIFICITY, SUBCELLULAR
LOCATION, AND BIOPHYSICOCHEMICAL PROPERTIES.
PubMed=16330770; DOI=10.1073/pnas.0506483102;
Otsuka M., Matsumoto T., Morimoto R., Arioka S., Omote H.,
Moriyama Y.;
"A human transporter protein that mediates the final excretion step
for toxic organic cations.";
Proc. Natl. Acad. Sci. U.S.A. 102:17923-17928(2005).
[6]
SUBCELLULAR LOCATION.
PubMed=16641166; DOI=10.1152/ajpcell.00090.2006;
Hiasa M., Matsumoto T., Komatsu T., Moriyama Y.;
"Wide variety of locations for rodent MATE1, a transporter protein
that mediates the final excretion step for toxic organic cations.";
Am. J. Physiol. 291:C678-C686(2006).
[7]
FUNCTION.
PubMed=16996621; DOI=10.1016/j.tips.2006.09.001;
Omote H., Hiasa M., Matsumoto T., Otsuka M., Moriyama Y.;
"The MATE proteins as fundamental transporters of metabolic and
xenobiotic organic cations.";
Trends Pharmacol. Sci. 27:587-593(2006).
[8]
FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, AND TISSUE SPECIFICITY.
PubMed=17509534; DOI=10.1016/j.bcp.2007.04.010;
Tanihara Y., Masuda S., Sato T., Katsura T., Ogawa O., Inui K.;
"Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin
extrusions/H(+)-organic cation antiporters.";
Biochem. Pharmacol. 74:359-371(2007).
[9]
FUNCTION.
PubMed=17582384; DOI=10.1016/j.bcp.2007.03.004;
Yokoo S., Yonezawa A., Masuda S., Fukatsu A., Katsura T., Inui K.;
"Differential contribution of organic cation transporters, OCT2 and
MATE1, in platinum agent-induced nephrotoxicity.";
Biochem. Pharmacol. 74:477-487(2007).
[10]
FUNCTION.
PubMed=17495125; DOI=10.1124/jpet.107.123554;
Chen Y., Zhang S., Sorani M., Giacomini K.M.;
"Transport of paraquat by human organic cation transporters and
multidrug and toxic compound extrusion family.";
J. Pharmacol. Exp. Ther. 322:695-700(2007).
[11]
ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
PubMed=22814378; DOI=10.1073/pnas.1210303109;
Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
Aldabe R.;
"N-terminal acetylome analyses and functional insights of the N-
terminal acetyltransferase NatB.";
Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
-!- FUNCTION: Solute transporter for tetraethylammonium (TEA), 1-
methyl-4-phenylpyridinium (MPP), cimetidine, N-methylnicotinamide
(NMN), metformin, creatinine, guanidine, procainamide, topotecan,
estrone sulfate, acyclovir, ganciclovir and also the zwitterionic
cephalosporin, cephalexin and cephradin. Seems to also play a role
in the uptake of oxaliplatin (a new platinum anticancer agent).
Able to transport paraquat (PQ or N,N-dimethyl-4-4'-bipiridinium);
a widely used herbicid. Responsible for the secretion of cationic
drugs across the brush border membranes.
{ECO:0000269|PubMed:16330770, ECO:0000269|PubMed:16996621,
ECO:0000269|PubMed:17495125, ECO:0000269|PubMed:17509534,
ECO:0000269|PubMed:17582384}.
-!- BIOPHYSICOCHEMICAL PROPERTIES:
Kinetic parameters:
KM=0.38 mM for TEA {ECO:0000269|PubMed:16330770,
ECO:0000269|PubMed:17509534};
KM=0.10 mM for MPP {ECO:0000269|PubMed:16330770,
ECO:0000269|PubMed:17509534};
KM=0.17 mM for cimetidine {ECO:0000269|PubMed:16330770,
ECO:0000269|PubMed:17509534};
KM=0.78 mM for metformin {ECO:0000269|PubMed:16330770,
ECO:0000269|PubMed:17509534};
KM=2.1 mM for guanidine {ECO:0000269|PubMed:16330770,
ECO:0000269|PubMed:17509534};
KM=1.23 mM for procainamide {ECO:0000269|PubMed:16330770,
ECO:0000269|PubMed:17509534};
KM=0.07 mM for topotecan {ECO:0000269|PubMed:16330770,
ECO:0000269|PubMed:17509534};
KM=0.47 mM for estrone sulfate {ECO:0000269|PubMed:16330770,
ECO:0000269|PubMed:17509534};
KM=2.64 mM for acyclovir {ECO:0000269|PubMed:16330770,
ECO:0000269|PubMed:17509534};
KM=5.12 mM for ganciclovir {ECO:0000269|PubMed:16330770,
ECO:0000269|PubMed:17509534};
Vmax=1.185 nmol/min/mg enzyme toward TEA
{ECO:0000269|PubMed:16330770, ECO:0000269|PubMed:17509534};
Vmax=0.735 nmol/min/mg enzyme toward MPP
{ECO:0000269|PubMed:16330770, ECO:0000269|PubMed:17509534};
Vmax=0.135 nmol/min/mg enzyme toward cimetidine
{ECO:0000269|PubMed:16330770, ECO:0000269|PubMed:17509534};
Vmax=2.23 nmol/min/mg enzyme toward metformin
{ECO:0000269|PubMed:16330770, ECO:0000269|PubMed:17509534};
Vmax=0.89 nmol/min/mg enzyme toward guanidine
{ECO:0000269|PubMed:16330770, ECO:0000269|PubMed:17509534};
Vmax=3.78 nmol/min/mg enzyme toward procainamide
{ECO:0000269|PubMed:16330770, ECO:0000269|PubMed:17509534};
Vmax=0.21 nmol/min/mg enzyme toward topotecan
{ECO:0000269|PubMed:16330770, ECO:0000269|PubMed:17509534};
Vmax=0.265 nmol/min/mg enzyme toward estrone sulfate
{ECO:0000269|PubMed:16330770, ECO:0000269|PubMed:17509534};
Vmax=0.62 nmol/min/mg enzyme toward acyclovir
{ECO:0000269|PubMed:16330770, ECO:0000269|PubMed:17509534};
Vmax=1.08 nmol/min/mg enzyme toward ganciclovir
{ECO:0000269|PubMed:16330770, ECO:0000269|PubMed:17509534};
pH dependence:
Optimum pH is 8.5. Active from pH 6 to 8.5.
{ECO:0000269|PubMed:16330770, ECO:0000269|PubMed:17509534};
-!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:16330770,
ECO:0000269|PubMed:16641166}; Multi-pass membrane protein
{ECO:0000269|PubMed:16330770, ECO:0000269|PubMed:16641166}.
Note=Predominantly localized at the plasma membrane but also found
in intracellular organelles.
-!- ALTERNATIVE PRODUCTS:
Event=Alternative splicing; Named isoforms=3;
Name=1;
IsoId=Q96FL8-1; Sequence=Displayed;
Name=2;
IsoId=Q96FL8-2; Sequence=VSP_029903, VSP_029904;
Note=No experimental confirmation available.;
Name=3;
IsoId=Q96FL8-3; Sequence=VSP_029905;
Note=No experimental confirmation available.;
-!- TISSUE SPECIFICITY: Expressed in adrenal gland, and to a lower
extent in liver, skeletal muscle and kidney (especially found in
luminal membranes of the urinary tubules, bile caniculi and brush
border membranes). {ECO:0000269|PubMed:16330770,
ECO:0000269|PubMed:17509534}.
-!- SIMILARITY: Belongs to the multi antimicrobial extrusion (MATE)
(TC 2.A.66.1) family. {ECO:0000305}.
-!- SEQUENCE CAUTION:
Sequence=AAH50592.1; Type=Erroneous initiation; Evidence={ECO:0000305};
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
-----------------------------------------------------------------------
EMBL; AK001709; BAA91852.1; -; mRNA.
EMBL; AK222625; BAD96345.1; -; mRNA.
EMBL; CH471212; EAW50893.1; -; Genomic_DNA.
EMBL; CH471212; EAW50894.1; -; Genomic_DNA.
EMBL; BC010661; AAH10661.1; -; mRNA.
EMBL; BC050592; AAH50592.1; ALT_INIT; mRNA.
EMBL; BC058882; AAH58882.1; -; mRNA.
CCDS; CCDS11209.1; -. [Q96FL8-1]
RefSeq; NP_060712.2; NM_018242.2. [Q96FL8-1]
UniGene; Hs.232054; -.
ProteinModelPortal; Q96FL8; -.
BioGrid; 120535; 42.
IntAct; Q96FL8; 2.
STRING; 9606.ENSP00000270570; -.
BindingDB; Q96FL8; -.
ChEMBL; CHEMBL1743126; -.
DrugBank; DB00787; Aciclovir.
DrugBank; DB01237; Bromodiphenhydramine.
DrugBank; DB00567; Cephalexin.
DrugBank; DB00501; Cimetidine.
DrugBank; DB00331; Metformin.
DrugBank; DB00877; Sirolimus.
GuidetoPHARMACOLOGY; 1216; -.
TCDB; 2.A.66.1.14; the multidrug/oligosaccharidyl-lipid/polysaccharide (mop) flippase superfamily.
iPTMnet; Q96FL8; -.
PhosphoSitePlus; Q96FL8; -.
BioMuta; SLC47A1; -.
DMDM; 74731723; -.
MaxQB; Q96FL8; -.
PaxDb; Q96FL8; -.
PeptideAtlas; Q96FL8; -.
PRIDE; Q96FL8; -.
Ensembl; ENST00000270570; ENSP00000270570; ENSG00000142494. [Q96FL8-1]
Ensembl; ENST00000395585; ENSP00000378951; ENSG00000142494. [Q96FL8-3]
GeneID; 55244; -.
KEGG; hsa:55244; -.
UCSC; uc002gvx.4; human. [Q96FL8-1]
CTD; 55244; -.
DisGeNET; 55244; -.
EuPathDB; HostDB:ENSG00000142494.13; -.
GeneCards; SLC47A1; -.
H-InvDB; HIX0013619; -.
HGNC; HGNC:25588; SLC47A1.
HPA; HPA021987; -.
MIM; 609832; gene.
neXtProt; NX_Q96FL8; -.
OpenTargets; ENSG00000142494; -.
PharmGKB; PA162403808; -.
eggNOG; KOG1347; Eukaryota.
eggNOG; COG0534; LUCA.
GeneTree; ENSGT00390000015713; -.
HOGENOM; HOG000060313; -.
HOVERGEN; HBG056043; -.
InParanoid; Q96FL8; -.
KO; K03327; -.
OMA; LCMEWWA; -.
OrthoDB; EOG091G06X2; -.
PhylomeDB; Q96FL8; -.
TreeFam; TF324441; -.
Reactome; R-HSA-425366; Transport of bile salts and organic acids, metal ions and amine compounds.
ChiTaRS; SLC47A1; human.
GeneWiki; SLC47A1; -.
GenomeRNAi; 55244; -.
PRO; PR:Q96FL8; -.
Proteomes; UP000005640; Chromosome 17.
Bgee; ENSG00000142494; -.
CleanEx; HS_SLC47A1; -.
ExpressionAtlas; Q96FL8; baseline and differential.
Genevisible; Q96FL8; HS.
GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
GO; GO:0005886; C:plasma membrane; TAS:Reactome.
GO; GO:0031982; C:vesicle; IBA:GO_Central.
GO; GO:0015238; F:drug transmembrane transporter activity; IBA:GO_Central.
GO; GO:0015307; F:drug:proton antiporter activity; TAS:Reactome.
GO; GO:0005451; F:monovalent cation:proton antiporter activity; IBA:GO_Central.
GO; GO:0006855; P:drug transmembrane transport; IBA:GO_Central.
GO; GO:0015695; P:organic cation transport; IBA:GO_Central.
GO; GO:0055085; P:transmembrane transport; TAS:Reactome.
InterPro; IPR002528; MATE_fam.
Pfam; PF01554; MatE; 2.
TIGRFAMs; TIGR00797; matE; 1.
1: Evidence at protein level;
Acetylation; Alternative splicing; Cell membrane; Complete proteome;
Membrane; Polymorphism; Reference proteome; Transmembrane;
Transmembrane helix; Transport.
CHAIN 1 570 Multidrug and toxin extrusion protein 1.
/FTId=PRO_0000312845.
TOPO_DOM 1 37 Cytoplasmic. {ECO:0000255}.
TRANSMEM 38 58 Helical. {ECO:0000255}.
TOPO_DOM 59 72 Extracellular. {ECO:0000255}.
TRANSMEM 73 93 Helical. {ECO:0000255}.
TOPO_DOM 94 123 Cytoplasmic. {ECO:0000255}.
TRANSMEM 124 144 Helical. {ECO:0000255}.
TOPO_DOM 145 152 Extracellular. {ECO:0000255}.
TRANSMEM 153 173 Helical. {ECO:0000255}.
TOPO_DOM 174 176 Cytoplasmic. {ECO:0000255}.
TRANSMEM 177 197 Helical. {ECO:0000255}.
TOPO_DOM 198 216 Extracellular. {ECO:0000255}.
TRANSMEM 217 237 Helical. {ECO:0000255}.
TOPO_DOM 238 256 Cytoplasmic. {ECO:0000255}.
TRANSMEM 257 276 Helical. {ECO:0000255}.
TOPO_DOM 277 295 Extracellular. {ECO:0000255}.
TRANSMEM 296 316 Helical. {ECO:0000255}.
TOPO_DOM 317 336 Cytoplasmic. {ECO:0000255}.
TRANSMEM 337 357 Helical. {ECO:0000255}.
TOPO_DOM 358 370 Extracellular. {ECO:0000255}.
TRANSMEM 371 391 Helical. {ECO:0000255}.
TOPO_DOM 392 408 Cytoplasmic. {ECO:0000255}.
TRANSMEM 409 429 Helical. {ECO:0000255}.
TOPO_DOM 430 437 Extracellular. {ECO:0000255}.
TRANSMEM 438 458 Helical. {ECO:0000255}.
TOPO_DOM 459 546 Cytoplasmic. {ECO:0000255}.
TRANSMEM 547 567 Helical. {ECO:0000255}.
TOPO_DOM 568 570 Extracellular. {ECO:0000255}.
MOD_RES 1 1 N-acetylmethionine.
{ECO:0000244|PubMed:22814378}.
VAR_SEQ 286 290 ILGMV -> LYEDG (in isoform 2).
{ECO:0000303|PubMed:15489334}.
/FTId=VSP_029903.
VAR_SEQ 291 570 Missing (in isoform 2).
{ECO:0000303|PubMed:15489334}.
/FTId=VSP_029904.
VAR_SEQ 559 570 VGILVRFYVRIQ -> AGVRWCDHSSLQPRTLGLQAILLCQ
PPE (in isoform 3).
{ECO:0000303|PubMed:15489334}.
/FTId=VSP_029905.
VARIANT 338 338 V -> I (in dbSNP:rs35790011).
/FTId=VAR_037587.
MUTAGEN 273 273 E->Q: No change in subcellular location
and abolition of MATE1-dependent TEA
transport activity.
{ECO:0000269|PubMed:16330770}.
CONFLICT 50 50 L -> R (in Ref. 2; BAD96345).
{ECO:0000305}.
CONFLICT 309 309 P -> L (in Ref. 1; BAA91852).
{ECO:0000305}.
CONFLICT 448 448 F -> L (in Ref. 2; BAD96345).
{ECO:0000305}.
CONFLICT 507 507 N -> D (in Ref. 2; BAD96345).
{ECO:0000305}.
SEQUENCE 570 AA; 61922 MW; CA940CBC2F6F5CC4 CRC64;
MEAPEEPAPV RGGPEATLEV RGSRCLRLSA FREELRALLV LAGPAFLVQL MVFLISFISS
VFCGHLGKLE LDAVTLAIAV INVTGVSVGF GLSSACDTLI SQTYGSQNLK HVGVILQRSA
LVLLLCCFPC WALFLNTQHI LLLFRQDPDV SRLTQTYVTI FIPALPATFL YMLQVKYLLN
QGIVLPQIVT GVAANLVNAL ANYLFLHQLH LGVIGSALAN LISQYTLALL LFLYILGKKL
HQATWGGWSL ECLQDWASFL RLAIPSMLML CMEWWAYEVG SFLSGILGMV ELGAQSIVYE
LAIIVYMVPA GFSVAASVRV GNALGAGDME QARKSSTVSL LITVLFAVAF SVLLLSCKDH
VGYIFTTDRD IINLVAQVVP IYAVSHLFEA LACTSGGVLR GSGNQKVGAI VNTIGYYVVG
LPIGIALMFA TTLGVMGLWS GIIICTVFQA VCFLGFIIQL NWKKACQQAQ VHANLKVNNV
PRSGNSALPQ DPLHPGCPEN LEGILTNDVG KTGEPQSDQQ MRQEEPLPEH PQDGAKLSRK
QLVLRRGLLL LGVFLILLVG ILVRFYVRIQ
Related products :
GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
Fax 0032 16 50 90 45
info@gentaur.com | Gentaur
GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur
GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50
Fax 01 43 25 01 60
RCS Paris B 484 237 888
SIRET 48423788800017
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
france@gentaur.com | Gentaur
GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88
Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur
GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel: 0208-080893 Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62 SWIFT RABONL2U
GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur
ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF
GENTAUR Poland Sp. z o.o.
ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX 058 710 33 48
poland@gentaur.com | Gentaur
Other countries
Österreich +43720880899
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Danmark +4569918806
Finland Helsset +358942419041
Magyarország Budapest +3619980547
Ireland Dublin+35316526556
Luxembourg+35220880274
Norge Oslo+4721031366
Sverige Stockholm+46852503438
Schweiz Züri+41435006251
US New York+17185132983
GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo
Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur
Pathways :
WP1502: Mitochondrial biogenesis
WP1909: Signal regulatory protein (SIRP) family interactions
WP211: BMP signaling pathway
WP2199: Seed Development
WP1049: G Protein Signaling Pathways
WP1165: G Protein Signaling Pathways
WP1371: G Protein Signaling Pathways
WP1438: Influenza A virus infection
WP1485: Interactions between CFTR and other ion channels
WP1493: Carbon assimilation C4 pathway
WP1531: Vitamin D synthesis
WP1566: Citrate cycle (TCA cycle)
WP1613: 1,4-Dichlorobenzene degradation
WP1616: ABC transporters
WP1624: Bacterial secretion system
WP1625: Base excision repair
WP1644: DNA replication
WP1650: Fluorobenzoate degradation
WP1654: gamma-Hexachlorocyclohexane degradation
WP1657: Glycerolipid metabolism
WP1659: Glycine, serine and threonine metabolism
WP1661: Glyoxylate and dicarboxylate metabolism
WP1663: Homologous recombination
WP1665: Limonene and pinene degradation
WP1672: Mismatch repair
Related Genes :
[emrE eb mvrC b0543 JW0531] Multidrug transporter EmrE (Efflux-multidrug resistance protein EmrE) (Ethidium resistance protein) (Methyl viologen resistance protein C)
[ABCC2 CMOAT CMOAT1 CMRP MRP2] Canalicular multispecific organic anion transporter 1 (ATP-binding cassette sub-family C member 2) (Canalicular multidrug resistance protein) (Multidrug resistance-associated protein 2)
[acrB acrE b0462 JW0451] Multidrug efflux pump subunit AcrB (AcrAB-TolC multidrug efflux pump subunit AcrB) (Acridine resistance protein B)
[mdtK norE norM ydhE b1663 JW1655] Multidrug resistance protein MdtK (Multidrug-efflux transporter)
[Abcb1a Abcb4 Mdr1a Mdr3 Pgy-3 Pgy3] Multidrug resistance protein 1A (EC 3.6.3.44) (ATP-binding cassette sub-family B member 1A) (MDR1A) (Multidrug resistance protein 3) (P-glycoprotein 3)
[Abcb4 Mdr2 Pgy-2 Pgy2] Phosphatidylcholine translocator ABCB4 (ATP-binding cassette sub-family B member 4) (Multidrug resistance protein 2) (Multidrug resistance protein 3) (EC 3.6.3.44) (P-glycoprotein 2) (P-glycoprotein 3)
[acrA lir mtcA b0463 JW0452] Multidrug efflux pump subunit AcrA (AcrAB-TolC multidrug efflux pump subunit AcrA) (Acridine resistance protein A)
[Abcc2 Cmoat Cmrp Mrp2] Canalicular multispecific organic anion transporter 1 (ATP-binding cassette sub-family C member 2) (Canalicular multidrug resistance protein) (Multidrug resistance-associated protein 2)
[Abcb4 Mdr2 Pgp3 Pgy2] Phosphatidylcholine translocator ABCB4 (ATP-binding cassette sub-family B member 4) (Multidrug resistance protein 2) (Multidrug resistance protein 3) (EC 3.6.3.44) (P-glycoprotein 2) (P-glycoprotein 3)
[ABCC1 MRP MRP1] Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)
[MDR1 BEN BMR1 CAALFM_C603170CA CaO19.13047 CaO19.5604] Multidrug resistance protein 1 (Benomyl resistance protein 1)
[ABCB1 MDR1 PGY1] Multidrug resistance protein 1 (EC 3.6.3.44) (ATP-binding cassette sub-family B member 1) (P-glycoprotein 1) (CD antigen CD243)
[mdfA cmlA cmr b0842 JW0826] Multidrug transporter MdfA (Chloramphenicol resistance pump Cmr)
[Abcc1 Mrp1] Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)
[ABCB4 MDR3 PGY3] Phosphatidylcholine translocator ABCB4 (ATP-binding cassette sub-family B member 4) (Multidrug resistance protein 3) (EC 3.6.3.44) (P-glycoprotein 3)
[acrZ ybhT b0762 JW5102] Multidrug efflux pump accessory protein AcrZ (AcrAB-TolC multidrug efflux pump accessory protein AcrZ) (Acridine resistance protein Z)
[DTX47 EDS5 IAP1 SCORD3 SID1 At4g39030 F19H22.130] Protein DETOXIFICATION 47, chloroplastic (AtDTX47) (Multidrug and toxic compound extrusion protein 47) (MATE protein 47) (Protein ENHANCED DISEASE SUSCEPTIBILITY 5) (Protein EDS5) (Protein IMPORTANT FOR THE ARR PATHWAY 1) (Protein IAP1) (Protein SALICYLIC ACID INDUCTION DEFICIENT 1) (Protein SID1) (Protein SUSCEPTIBLE TO CORONATINE-DEFICIENT PST DC3000 3) (Protein SCORD3)
[Slc47a1 Mate1] Multidrug and toxin extrusion protein 1 (MATE-1) (rMATE-1) (Solute carrier family 47 member 1)
[ABCC3 CMOAT2 MLP2 MRP3] Canalicular multispecific organic anion transporter 2 (ATP-binding cassette sub-family C member 3) (Multi-specific organic anion transporter D) (MOAT-D) (Multidrug resistance-associated protein 3)
[ABCC5 MRP5] Multidrug resistance-associated protein 5 (ATP-binding cassette sub-family C member 5) (Multi-specific organic anion transporter C) (MOAT-C) (SMRP) (pABC11)
[tolC colE1-i mtcB mukA refI toc weeA b3035 JW5503] Outer membrane protein TolC (Multidrug efflux pump subunit TolC) (Outer membrane factor TolC)
[DTX43 FRD3 MAN1 At3g08040 F17A17.38 T8G24.8] Protein DETOXIFICATION 43 (AtDTX43) (Multidrug and toxic compound extrusion protein 43) (MATE protein 43) (Protein FERRIC REDUCTASE DEFECTIVE 3) (AtFRD3) (Protein MANGANESE ACCUMULATOR 1)
[DTX48 ABS4 BCD1 ZF14 ZRZ At1g58340 F19C14.5] Protein DETOXIFICATION 48 (AtDTX48) (Multidrug and toxic compound extrusion protein 48) (MATE protein 48) (Protein ABNORMAL SHOOT 4) (Protein BUSH-AND-CHLOROTIC-DWARF 1) (Protein BCD1) (Protein ZRIZI)
[SLC47A1 MATE1] Multidrug and toxin extrusion protein 1 (MATE-1) (hMATE-1) (Solute carrier family 47 member 1)
[SLC47A2 MATE2] Multidrug and toxin extrusion protein 2 (MATE-2) (hMATE-2) (Kidney-specific H(+)/organic cation antiporter) (Solute carrier family 47 member 2)
[ABCC4 MRP4] Multidrug resistance-associated protein 4 (ATP-binding cassette sub-family C member 4) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B)
[Abcb1 Mdr1 Mdr1b Pgy1] Multidrug resistance protein 1 (EC 3.6.3.44) (ATP-binding cassette sub-family B member 1) (P-glycoprotein 1) (CD antigen CD243)
[Abcb1b Abcb1 Mdr1 Mdr1b Pgy1 Pgy1-1] Multidrug resistance protein 1B (EC 3.6.3.44) (ATP-binding cassette sub-family B member 1B) (P-glycoprotein 1) (CD antigen CD243)
[DTX50 ABS3L1 At5g52050 MSG15.13] Protein DETOXIFICATION 50 (AtDTX50) (DETOXIFICATION EFFLUX CARRIER 50) (Multidrug and toxic compound extrusion protein 50) (MATE protein 50) (Protein ABNORMAL SHOOT 3-like 1)
[DTX51 ABS3 ADP1 ADS1 NIC4 At4g29140 F19B15.170] Protein DETOXIFICATION 51 (AtDTX51) (Multidrug and toxic compound extrusion protein 51) (MATE protein 51) (Protein ABNORMAL SHOOT 3) (Protein ACTIVATED DISEASE SUSCEPTIBILITY 1) (Protein ADS1) (Protein ALTERED DEVELOPMENT PROGRAM 1) (Protein ADP1) (Protein NOVEL ION CARRIER 4) (Protein NIC4)
Bibliography :
No related Items
Enter catalog number :
Favorites Pages:
No Favorits